Covington Capital Management’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | $25.8M | Sell |
50,851
-487
| -0.9% | -$273K | 1.11% | 19 |
|
|
2022
Q2 | $27.9M | Buy |
51,338
+820
| +2% | +$451K | 1.13% | 19 |
|
|
2022
Q1 | $29.8M | Buy |
50,518
+284
| +0.6% | +$163K | 1.07% | 21 |
|
|
2021
Q4 | $33.5M | Buy |
50,234
+105
| +0.2% | +$65.6K | 1.16% | 18 |
|
|
2021
Q3 | $28.6M | Buy |
50,129
+930
| +2% | +$510K | 1.08% | 22 |
|
|
2021
Q2 | $24.8M | Buy |
49,199
+1,087
| +2% | +$513K | 0.97% | 29 |
|
|
2021
Q1 | $22M | Buy |
48,112
+3,843
| +9% | +$1.83M | 0.94% | 29 |
|
|
2020
Q4 | $20.6M | Buy |
44,269
+463
| +1% | +$217K | 0.93% | 32 |
|
|
2020
Q3 | $19.3M | Buy |
43,806
+339
| +0.8% | +$140K | 0.96% | 31 |
|
|
2020
Q2 | $15.8M | Buy |
43,467
+1,900
| +5% | +$637K | 0.88% | 34 |
|
|
2020
Q1 | $11.8M | Buy |
41,567
+734
| +2% | +$231K | 0.77% | 39 |
|
|
2019
Q4 | $13.3M | Buy |
40,833
+1,365
| +3% | +$414K | 0.7% | 45 |
|
|
2019
Q3 | $11.5M | Buy |
39,468
+3,216
| +9% | +$921K | 0.66% | 44 |
|
|
2019
Q2 | $10.6M | Buy |
36,252
+5,333
| +17% | +$1.47M | 0.63% | 47 |
|
|
2019
Q1 | $8.46M | Buy |
30,919
+4,983
| +19% | +$1.24M | 0.52% | 53 |
|
|
2018
Q4 | $5.8M | Buy |
25,936
+3,755
| +17% | +$881K | 0.4% | 76 |
|
|
2018
Q3 | $5.41M | Buy |
22,181
+2,134
| +11% | +$491K | 0.33% | 84 |
|
|
2018
Q2 | $4.15M | Buy |
20,047
+17,080
| +576% | +$3.63M | 0.27% | 99 |
|
|
2018
Q1 | $613K | Buy |
2,967
+666
| +29% | +$140K | 0.04% | 210 |
|
|
2017
Q4 | $437K | Sell |
2,301
-44
| -2% | -$8.43K | 0.03% | 232 |
|
|
2017
Q3 | $444K | Buy |
2,345
+201
| +9% | +$36.4K | 0.03% | 229 |
|
|
2017
Q2 | $374K | Buy |
2,144
+20
| +0.9% | +$3.36K | 0.03% | 204 |
|
|
2017
Q1 | $326K | Sell |
2,124
-200
| -9% | -$30.6K | 0.03% | 200 |
|
|
2016
Q4 | $328K | Sell |
2,324
-100
| -4% | -$14.7K | 0.03% | 195 |
|
|
2016
Q3 | $386K | Hold |
2,424
| – | – | 0.04% | 187 |
|
|
2016
Q2 | $358K | Buy |
2,424
+68
| +3% | +$10K | 0.03% | 193 |
|
|
2016
Q1 | $334K | Buy |
2,356
+32
| +1% | +$4.29K | 0.03% | 198 |
|
|
2015
Q4 | $330K | Hold |
2,324
| – | – | 0.03% | 199 |
|
|
2015
Q3 | $284K | Hold |
2,324
| – | – | 0.03% | 207 |
|
|
2015
Q2 | $302K | Hold |
2,324
| – | – | 0.03% | 218 |
|
|
2015
Q1 | $312K | Hold |
2,324
| – | – | 0.03% | 198 |
|
|
2014
Q4 | $291K | Sell |
2,324
-1,423
| -38% | -$173K | 0.03% | 227 |
|
|
2014
Q3 | $456K | Hold |
3,747
| – | – | 0.04% | 201 |
|
|
2014
Q2 | $450K | Sell |
3,747
-800
| -18% | -$94.2K | 0.04% | 200 |
|
|
2014
Q1 | $547K | Hold |
4,547
| – | – | 0.05% | 182 |
|
|
2013
Q4 | $506K | Buy |
4,547
+2,047
| +82% | +$204K | 0.05% | 185 |
|
|
2013
Q3 | $230K | Sell |
2,500
-1,000
| -29% | -$90.4K | 0.03% | 213 |
|
|
2013
Q2 | $296K | Buy |
+3,500
| New | +$291K | 0.04% | 196 |
|
Other funds holding TMO
Covington Capital Management's TMO Position: Q3 2022 in Review
Covington Capital Management reduced its Thermo Fisher Scientific (TMO) stake by 0.95% in Q3 2022, selling an estimated $273K and leaving 50,851 shares worth $25.8M. The position accounts for 1.11% of the portfolio, ranked #19.
Covington Capital Management first reported a position in TMO in Q2 2013 and has held it in 38 quarters since. The position peaked at $33.5M in Q4 2021. 2,266 funds tracked by Wall St. Rank hold TMO as of Q3 2022.
- Covington Capital Management held 50,851 shares of Thermo Fisher Scientific worth $25.8M as of Q3 2022.
- Covington Capital Management sold 487 Thermo Fisher Scientific shares in Q3 2022, an estimated $273K.
- Thermo Fisher Scientific made up 1.11% of Covington Capital Management's portfolio in Q3 2022, its #19 holding.
- Covington Capital Management first reported a position in Thermo Fisher Scientific in Q2 2013 and has held it in 38 quarters since.
- Covington Capital Management's Thermo Fisher Scientific position peaked at $33.5M in Q4 2021.
- 2,266 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q3 2022.
Based on Covington Capital Management's 13F filing for Q3 2022, filed 15 Nov 2022.